Prospective Multicenter Study to Characterize the REAL-WORLD EVIDENCE Regarding Safety and Performance of the PTCA Catheters Family
1 other identifier
observational
60
1 country
1
Brief Summary
The purpose of this Post market Study is to collect clinical data of the Arthesys PTCA catheters family during angioplasty intervention of coronary vessels or coronary bypass graft stenosis to support MDR submission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2022
CompletedFirst Posted
Study publicly available on registry
February 10, 2022
CompletedStudy Start
First participant enrolled
July 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2023
CompletedJuly 21, 2023
July 1, 2023
11 months
January 31, 2022
July 20, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Efficacy endpoint
Balloon successfully reaching and crossing target location, successful inflation, deflation, and retrieval in the guiding catheter
Up to end of PTCA procedure
Safety endpoint
Successful balloon dilatation without device related adverse event during the dilatation procedure
Up to end of PTCA procedure
Secondary Outcomes (2)
Performance - pre-dilatation
Up to end of PTCA procedure
Performance - post-dilatation
Up to end of PTCA procedure
Interventions
Angioplasty intervention of coronary vessels or coronary bypass graft stenosis
Eligibility Criteria
Patients undergoing PTCA procedure
You may qualify if:
- Patient with a Percutaneous intervention to a native coronary or coronary bypass graft indication
- Patient \>18 years
- Patient who understands the trial requirements and the treatment procedures and provides written informed consent
You may not qualify if:
- \- Patients will not be included if they are under judicial protection, guardianship or curatorship or if they are deprived of their liberty by judicial or administrative decision.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arthesyslead
Study Sites (1)
Hôpital Saint Louis
La Rochelle, 17000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2022
First Posted
February 10, 2022
Study Start
July 29, 2022
Primary Completion
June 20, 2023
Study Completion
July 15, 2023
Last Updated
July 21, 2023
Record last verified: 2023-07